321 related articles for article (PubMed ID: 23566831)
21. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis.
Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS
Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535
[TBL] [Abstract][Full Text] [Related]
22. [Intramuscular injection of lentivirus-mediated EPAS1 gene improves hind limb ischemia and its mechanism in a rat model of peripheral artery vascular disease].
Wang Z; Gu H; Yang F; Xie H; Sheng L; Li M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1539-1543. PubMed ID: 29268860
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
24. Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells.
Loboda A; Jazwa A; Wegiel B; Jozkowicz A; Dulak J
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):347-55. PubMed ID: 16309584
[TBL] [Abstract][Full Text] [Related]
25. [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision].
Herold J; Said S; Braun-Dullaeus R
Zentralbl Chir; 2014 Oct; 139(5):508-17. PubMed ID: 24089345
[TBL] [Abstract][Full Text] [Related]
26. Gene-based therapies in patients with critical limb ischemia.
Kitrou P; Karnabatidis D; Brountzos E; Katsanos K; Reppas L; Spiliopoulos S
Expert Opin Biol Ther; 2017 Apr; 17(4):449-456. PubMed ID: 28133976
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
Ripa RS
Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
[TBL] [Abstract][Full Text] [Related]
28. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of vascular endothelial growth factor and granulocyte colony-stimulating factor double gene therapy in mouse limb ischemia.
Sacramento CB; da Silva FH; Nardi NB; Yasumura EG; Baptista-Silva JC; Beutel A; de Campos RR; de Moraes JZ; Junior HS; Samoto VY; Borojevic R; Han SW
J Gene Med; 2010 Mar; 12(3):310-9. PubMed ID: 20077434
[TBL] [Abstract][Full Text] [Related]
31. Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.
Grochot-Przeczek A; Kotlinowski J; Kozakowska M; Starowicz K; Jagodzinska J; Stachurska A; Volger OL; Bukowska-Strakova K; Florczyk U; Tertil M; Jazwa A; Szade K; Stepniewski J; Loboda A; Horrevoets AJ; Dulak J; Jozkowicz A
Antioxid Redox Signal; 2014 Apr; 20(11):1677-92. PubMed ID: 24206054
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
33. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P
Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820
[TBL] [Abstract][Full Text] [Related]
34. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1.
Lin HH; Chen YH; Chang PF; Lee YT; Yet SF; Chau LY
J Mol Cell Cardiol; 2008 Jul; 45(1):44-55. PubMed ID: 18534615
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor overexpression does not enhance adipose stromal cell-induced protection on muscle damage in critical limb ischemia.
Olea FD; Locatelli P; Hnatiuk A; De Lorenzi A; Valdivieso L; Rocha E; Ramírez R; Laguens R; Crottogini A
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):184-8. PubMed ID: 25414254
[TBL] [Abstract][Full Text] [Related]
36. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
Guo Y; Liu C; He J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
[TBL] [Abstract][Full Text] [Related]
37. Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-κB, and MAPK pathways.
Wang L; Kou MC; Weng CY; Hu LW; Wang YJ; Wu MJ
Arch Toxicol; 2012 Jun; 86(6):879-96. PubMed ID: 22488045
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
Anisimov A; Tvorogov D; Alitalo A; Leppänen VM; An Y; Han EC; Orsenigo F; Gaál EI; Holopainen T; Koh YJ; Tammela T; Korpisalo P; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Dejana E; Koh GY; Choi C; Saharinen P; Alitalo K
Circulation; 2013 Jan; 127(4):424-34. PubMed ID: 23357661
[TBL] [Abstract][Full Text] [Related]
39. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097
[TBL] [Abstract][Full Text] [Related]
40. Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy.
Serra J; Alves CPA; Brito L; Monteiro GA; Cabral JMS; Prazeres DMF; da Silva CL
Hum Gene Ther; 2019 Mar; 30(3):316-329. PubMed ID: 30200778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
